Chengdu Bright Eye Hospital Group Co., Ltd. (SZSE:301239) Insiders, Who Hold 44% of the Firm Would Be Disappointed by the Recent Pullback
Chengdu Bright Eye Hospital Group Co., Ltd. (SZSE:301239) Insiders, Who Hold 44% of the Firm Would Be Disappointed by the Recent Pullback
Key Insights
关键洞察
- Chengdu Bright Eye Hospital Group's significant insider ownership suggests inherent interests in company's expansion
- The top 3 shareholders own 50% of the company
- Institutions own 28% of Chengdu Bright Eye Hospital Group
- 成都明亮眼科医院集团显著的内部股权表明该公司在扩张方面的固有利益
- 前三大股东拥有公司50%的股份
- 机构持有成都明亮眼科医院集团28%的股份
A look at the shareholders of Chengdu Bright Eye Hospital Group Co., Ltd. (SZSE:301239) can tell us which group is most powerful. The group holding the most number of shares in the company, around 44% to be precise, is individual insiders. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
查看成都明亮眼科医院集团有限公司(深交所代码:301239)的股东可以告诉我们哪个集团最强大。 持有公司最多股份的集团,大约占44%的股份,主要是个人内部人士。 换句话说,这个集团从投资公司中得到的收益最多(或损失最多)。
As market cap fell to CN¥8.3b last week, insiders would have faced the highest losses than any other shareholder groups of the company.
上周市值降至83亿人民币,内部人士的损失将比公司的其他股东群体更高。
Let's take a closer look to see what the different types of shareholders can tell us about Chengdu Bright Eye Hospital Group.
让我们更仔细地看看不同类型的股东能告诉我们关于成都明眸医院集团的信息。
What Does The Institutional Ownership Tell Us About Chengdu Bright Eye Hospital Group?
机构持股对成都明眸医院集团意味着什么?
Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.
机构通常在向自己的投资者报告时,会与基准进行比较,因此一旦股票被纳入主要指数,他们通常对该股票会更加热情。我们预期大多数公司在登记时都会有一些机构,尤其是当它们正在增长时。
We can see that Chengdu Bright Eye Hospital Group does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Chengdu Bright Eye Hospital Group, (below). Of course, keep in mind that there are other factors to consider, too.
我们可以看到成都明眸医院集团确实有机构投资者,他们持有公司股票的较大部分。这意味着为这些机构工作的分析师已经查看了这只股票并且喜欢它。但和其他任何人一样,他们也可能是错的。如果两个大型机构投资者试图同时卖出某只股票,股票价格大幅下跌并不少见。因此,查看成都明眸医院集团过去的盈利轨迹是值得的(见下文)。当然,还要记住,还有其他因素需要考虑。
Chengdu Bright Eye Hospital Group is not owned by hedge funds. Looking at our data, we can see that the largest shareholder is Xuyang Xu with 43% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 4.0% and 3.1%, of the shares outstanding, respectively.
成都明亮眼科医院集团并不被对冲基金拥有。根据我们的数据,我们可以看到最大的股东是徐阳,持有43%的流通股。与此同时,第二和第三大股东,分别持有4.0%和3.1%的流通股。
A more detailed study of the shareholder registry showed us that 3 of the top shareholders have a considerable amount of ownership in the company, via their 50% stake.
对股东登记册的更详细研究显示,排名前几的大股东中有3个持有公司相当数量的股份,拥有50%的股份。
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. While there is some analyst coverage, the company is probably not widely covered. So it could gain more attention, down the track.
虽然研究公司机构持股数据是有意义的,但研究分析师情绪也同样重要,以了解风向如何。尽管有一定的分析师覆盖,但这家公司可能并没有被广泛报道。因此它在未来可能会获得更多关注。
Insider Ownership Of Chengdu Bright Eye Hospital Group
成都明亮眼科医院集团的内部持股
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
内幕交易者的定义在不同国家之间可能会略有不同,但董事会成员始终被计算在内。公司管理层运行业务,但首席执行官将向董事会负责,即使他或她是董事会的成员。
Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.
当内幕所有权表明领导者像真正的公司所有者那样思考时,这是积极的。然而,高内幕所有权也可能赋予公司内部小集团巨大的权力。在某些情况下,这可能是负面的。
Our most recent data indicates that insiders own a reasonable proportion of Chengdu Bright Eye Hospital Group Co., Ltd.. It has a market capitalization of just CN¥8.3b, and insiders have CN¥3.7b worth of shares in their own names. That's quite significant. Most would be pleased to see the board is investing alongside them. You may wish to access this free chart showing recent trading by insiders.
我们最新的数据表明,内部人士拥有成都明亮眼医院集团有限公司相当比例的股份。它的市值仅为83亿人民币,内部人士名下持有37亿人民币的股份。这是相当显著的。大多数人看到董事会与他们共同投资会感到高兴。您可能希望查看这张免费的图表,展示了内部人士最近的交易情况。
General Public Ownership
公众持股
The general public-- including retail investors -- own 19% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.
公众,包括散户投资者,拥有该公司的19%股份,因此不能被轻易忽视。这种所有权规模虽然相当可观,但如果决策与其他大股东不同,可能不足以改变公司政策。
Private Company Ownership
私有公司所有权
It seems that Private Companies own 8.9%, of the Chengdu Bright Eye Hospital Group stock. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.
似乎私营公司持有成都明眸医院集团8.9%的股票。单凭这一事实很难得出任何结论,因此值得研究一下这些私营公司的所有者。有时,内部人或其他相关方可能通过一家独立的私营公司对一家上市公司的股票有利益。
Next Steps:
下一步:
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with Chengdu Bright Eye Hospital Group , and understanding them should be part of your investment process.
我发现了解一家公司究竟由谁拥有非常有趣。但要真正获得洞察,我们还需要考虑其他信息。例如,要考虑投资风险这个始终存在的幽灵。我们已识别出成都明眸医院集团的2个警示信号,理解它们应该成为你的投资过程的一部分。
If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
如果你和我一样,可能想考虑这家公司是会增长还是会缩减。幸运的是,你可以查看这份免费报告,其中显示了分析师对其未来的预测。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注意:本文中的数字是根据过去十二个月的数据计算得出的,指的是截至财务报表日期的月份最后一天的12个月期间。这可能与完整年度的年报数字不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有反馈?对内容有疑虑?请直接与我们联系。或者,发送电子邮件至 editorial-team (at) simplywallst.com。
这篇来自Simply Wall St的文章是一般性的。我们根据历史数据和分析师预测提供评论,采用无偏见的方法,我们的文章并不旨在提供财务建议。它不构成对任何股票的买入或卖出建议,也未考虑到您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均没有持仓。